Onderneming Edge Therapeutics Inc Nasdaq
Aandelen
US2798701098
Biotechnologie & Medisch Onderzoek
Vakgebied
Managers
Managers | Titel | Leeftijd | Van |
---|---|---|---|
Frank Bedu-Addo
FOU | Founder | 59 | 15-03-19 |
Director of Finance/CFO | 55 | 04/12 | |
David Schaaf
CTO | Chief Tech/Sci/R&D Officer | - | 01-09-22 |
Spencer Brown
CMP | Compliance Officer | 54 | 01-06-22 |
Gregory Conn
CTO | Chief Tech/Sci/R&D Officer | 69 | 01-01-05 |
Joe J. Dervan
CTO | Chief Tech/Sci/R&D Officer | - | - |
Besturend
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
Stephen Glover
CHM | Chairman | 60 | 02-04-19 |
Otis Brawley
BRD | Director/Board Member | 64 | 03-11-20 |
Richard Sykes
BRD | Director/Board Member | 79 | 01-03-19 |
Director/Board Member | 65 | 21-02-20 | |
Gregory Freitag
BRD | Director/Board Member | 62 | 01-03-19 |
Frank Bedu-Addo
FOU | Founder | 59 | 15-03-19 |
Ilian Iliev
BRD | Director/Board Member | 48 | 08-04-20 |
Aandelenklasse
Stemming | Aantal | Vrij verhandelbaar | Bedrijfseigen aandelen | Drijvend Totaal | |
---|---|---|---|---|---|
Aandeel A | 1 | 36 679 275 | 35 209 588 ( 95,99 %) | 0 | 95,99 % |
Bedrijfsgegevens
Sector
Vaira. 1 jan. | Kapi. | |
---|---|---|
+7,78% | 113 mld. | |
+10,89% | 106 mld. | |
+0,41% | 22,27 mld. | |
-12,00% | 22,22 mld. | |
-5,99% | 19,43 mld. | |
-37,36% | 17,87 mld. | |
-5,67% | 17,24 mld. | |
+6,72% | 14,29 mld. | |
+35,75% | 12,52 mld. |